Cargando…
The Missing Link between (Un)druggable and Degradable KRAS
Autores principales: | De Vita, Elena, Maneiro, Maria, Tate, Edward W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453419/ https://www.ncbi.nlm.nih.gov/pubmed/32875070 http://dx.doi.org/10.1021/acscentsci.0c00920 |
Ejemplares similares
-
KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023) -
KRAS mutation: from undruggable to druggable in cancer
por: Huang, Lamei, et al.
Publicado: (2021) -
KRAS: A Druggable Target in Colon Cancer Patients
por: Negri, Francesca, et al.
Publicado: (2022) -
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
por: Baldelli, Elisa, et al.
Publicado: (2021) -
Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer
por: Seguin, Laetitia, et al.
Publicado: (2018)